Butterfly Network (BFLY) Net Income towards Common Stockholders (2020 - 2026)
Butterfly Network (BFLY) posted Net Income towards Common Stockholders of -$12.9 million for Q2 2026, down 1.84% sequentially from -$12.7 million in Q1 2026, and up 6.68% YoY from -$12.1 million in Q2 2025.
Butterfly Network (BFLY) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
Butterfly Network has reported Net Income towards Common Stockholders for 7 years, with the latest figure at -$12.9 million in Q2 2026.
- Quarterly Net Income towards Common Stockholders rose 6.68% year-over-year to -$12.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$74.8 million (down 19.14% YoY) and the FY2025 annual result came in at -$77.1 million, down 6.31% from the prior year.
- Net Income towards Common Stockholders eased to -$12.9 million in Q2 2026 per BFLY's latest filing, from -$12.7 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$12.7 million in Q1 2026 and troughed at -$54.7 million in Q3 2022.
- A 5-year average of -$26.5 million and a median of -$24.6 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders tumbled 6345.94% in 2022, then soared 58.97% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at -$33.7 million in 2022, then slumped by 30.91% to -$44.1 million in 2023, then jumped by 58.97% to -$18.1 million in 2024, then grew by 15.52% to -$15.3 million in 2025, then gained by 15.58% to -$12.9 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$12.9 million, -$12.7 million, and -$15.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Butterfly Network | 2.41 Bn | 2.28 Bn | 23.29 Mn | -12.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.91 Mn |
| Mar 31, 2026 | -12.68 Mn |
| Dec 31, 2025 | -15.28 Mn |
| Sep 30, 2025 | -33.97 Mn |
| Jun 30, 2025 | -13.83 Mn |
| Mar 31, 2025 | -13.97 Mn |
| Dec 31, 2024 | -18.10 Mn |
| Sep 30, 2024 | -16.92 Mn |
| Jun 30, 2024 | -15.71 Mn |
| Mar 31, 2024 | -21.76 Mn |
| Dec 31, 2023 | -44.12 Mn |
| Sep 30, 2023 | -27.37 Mn |
| Jun 30, 2023 | -28.67 Mn |
| Mar 31, 2023 | -33.54 Mn |
| Dec 31, 2022 | -33.70 Mn |
| Sep 30, 2022 | -54.74 Mn |
| Jun 30, 2022 | -35.80 Mn |
| Mar 31, 2022 | -44.48 Mn |
| Dec 31, 2021 | -15.22 Mn |
| Sep 30, 2021 | -13.56 Mn |